Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Neisseria meningitidis serogroup W-135 capsular polysaccharide antigen is a group-specific carbohydrate structure that forms the outer capsule of N. meningitidis bacteria belonging to serogroup W-135. This capsule is a major virulence factor, enabling the bacterium to evade host immune responses and cause invasive diseases such as meningitis and septicemia. It serves as a key component in vaccines to induce protective immunity.
Induces antibody production targeting the capsular polysaccharide, leading to opsonization and complement-mediated killing of Neisseria meningitidis serogroup W-135.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neisseria meningitidis serogroup W‑135 capsular polysaccharide antigen (None).